1 New Burlington Place
London W1S 2HR
United Kingdom
44 20 7399 2760
https://www.hikma.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - Specialty & Generic
Funcionários Integrais: 9.100
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Engineer Said Samih Taleb Darwazah | Executive Chairman | 2,27M | N/A | 1957 |
Mr. Riad Ali Mishlawi | CEO & Director | 893,1k | N/A | 1964 |
Mr. Mazen Samih Taleb Darwazah | Executive Vice Chairman & President of MENA | 1,86M | N/A | 1958 |
Mr. Khalid Waleed Hosny Al Nabilsi | Chief Financial Officer | N/A | N/A | 1972 |
Patricia Bousfield | Chief Information Officer | N/A | N/A | N/A |
Mr. Guy Featherstone | Associate Director of Investor Relations | N/A | N/A | N/A |
Mr. Samuel Park | General Counsel | N/A | N/A | N/A |
Mr. Bassam Wael Rushdi Kanaan CFA, CPA | Executive Vice President of Corporate Development and M&A | N/A | N/A | 1965 |
Mr. Hussein Omar Arkhagha | Chief People Officer | N/A | N/A | N/A |
Ms. Susan Ringdal | Executive Vice President of Strategic Planning & Global Affairs | N/A | N/A | N/A |
O QualityScore de governança da ISS da Hikma Pharmaceuticals PLC a partir de 1 de abril de 2024 é 7. As principais pontuações para Auditoria são: 6; Conselho: 9; Direitos de Acionistas: 7; Compensação: 3.